Skip to main content

Published locations for EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EASD: Alirocumab lipid-lowering benefits extend to patients with high-risk diabetes

User login

  • Reset your password
  • /content/easd-alirocumab-lipid-lowering-benefits-extend-patients-high-risk-diabetes
  • /familypracticenews/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients
  • /internalmedicinenews/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients
  • /clinicalendocrinologynews/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend
  • /diabeteshub/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients-high
  • /ecardiologynews/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients-high
  • /cardiology/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients-high-risk
  • /endocrinology/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients-high
  • /internalmedicine/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients
  • /familymedicine/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend-patients-high
  • /type-2-diabetes-icymi/article/103232/diabetes/easd-alirocumab-lipid-lowering-benefits-extend